DOVONEX

This brand name is authorized in Canada, Ireland, Japan, Malta, United Kingdom, United States, South Africa

Active ingredients

The drug DOVONEX contains one active pharmaceutical ingredient (API):

1 Calcipotriol UNII 143NQ3779B - CALCIPOTRIENE

Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing. Read about Calcipotriol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Dovonex Ointment	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D05AX02	Calcipotriol	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 01976133
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 201303, 30768, 381297
Country: IE	Health Products Regulatory Authority	Identifier(s): 68910, 68990
Country: JP	医薬品医療機器総合機構	Identifier(s): 2691701M1031
Country: MT	Medicines Authority	Identifier(s): MA1313/00301
Country: US	FDA, National Drug Code	Identifier(s): 50222-260
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/13.9.1/0270, 29/13.9.1/0762, Z/13.9.1/207